27.06.2024 14:15:19 - dpa-AFX: *LIGAND PARTNER VERONA PHARMA ANNOUNCES FDA APPROVAL OF OHTUVAYRE FOR MAINTENANCE TREATMENT OF COPD

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Ligand Pharmaceuticals A1C9RN NASDAQ 110,265 30.07.24 21:52:16 +1,515 +1,39% 109,670 110,430 109,800 108,750

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH